Skip to menu Skip to content Skip to footer

2014

Conference Publication

Interventions for Reduction of Left Ventricular Mass in Chronic Kidney Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Badve, S. V., Roberts, M. A., Palmer, S. C., Hiremath, S. S., Hawley, C. M., Perkovic, V., Whalley, G. A., Strippoli, G. F. M. and Johnson, D. W. (2014). Interventions for Reduction of Left Ventricular Mass in Chronic Kidney Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Interventions for Reduction of Left Ventricular Mass in Chronic Kidney Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

2014

Conference Publication

Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients

Mallett, A., Campbell, S., Van Eps, C., Hawley, C., Burke, J., Hughes, P., Kausman, J., Hewitt, I., Parnham, A., Szer, J., Tuckfield, A., Payne, S., Young, J. and Isbel, N. (2014). Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients. WILEY-BLACKWELL.

Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients

2014

Conference Publication

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

Rossi, M., Campbell, K. L., Johnson, D. W., Stanton, T., Pascoe, E. M., Hawley, C. M., Dimeski, G., Mcwhinney, B. C., Ungerer, J. P. and Isbel, N. M. (2014). Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. HOBOKEN: Wiley.

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

2014

Conference Publication

Research priorities in chronic kidney disease: a priority setting partnership

Tong, A., Crowe, S., Chando, S., Cass, A., Chadban, S. J., Chapman, J. R., Gallagher, M., Gillis, J., Hawley, C., Hill, S., Howard, K., Johnson, D. W., Kerr, P., Mathew, T., Mckenzie, A., Parker, D., Polkinghorne, K., Perkovic, V., Pollock, C., Strippoli, G. F. M., Tugwell, P., Walker, R. G., Webster, A. C., Wilson, A., Wong, G. and Craig, J. C. (2014). Research priorities in chronic kidney disease: a priority setting partnership. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Research priorities in chronic kidney disease: a priority setting partnership

2013

Journal Article

Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease

Rossi, M., Campbell, K.L., Johnson, D.W., Stanton, T., Vesey, D.A., Coombes, J.S., Weston, K.S., Hawley, C.M., McWhinney, B.C., Ungerer, J.P.J. and Isbel, N. (2013). Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease. Archives of Medical Research, 45 (4), 309-317. doi: 10.1016/j.arcmed.2014.04.002

Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease

2013

Journal Article

Estimated GFR reporting influences recommendations for dialysis initiation

Brimble, K. Scott, Mehrotra, Rajnish, Tonelli, Marcello, Hawley, Carmel M., Castledine, Clare, McDonald, Stephen P., Levidiotis, Vicki, Gangji, Azim S., Treleaven, Darin J., Margetts, Peter J. and Walsh, Michael (2013). Estimated GFR reporting influences recommendations for dialysis initiation. Journal of the American Society of Nephrology, 24 (11), 1737-1742. doi: 10.1681/ASN.2013010035

Estimated GFR reporting influences recommendations for dialysis initiation

2013

Journal Article

Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?

Campbell-Lloyd, Andrew J. M., Mundy, Julie, Deva, Rajeev, Lampe, Guy, Hawley, Carmel, Boyle, Glen, Griffin, Rayleene, Thompson, Charles and Shah, Pallav (2013). Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?. Heart Lung and Circulation, 22 (9), 759-766. doi: 10.1016/j.hlc.2013.01.014

Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?

2013

Journal Article

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes

Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Bannister, Kym M., Clayton, Philip A. and Johnson, David W. (2013). Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes. Clinical Journal of the American Society of Nephrology, 8 (9), 1556-1563. doi: 10.2215/CJN.12361212

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes

2013

Journal Article

Interventions for erythropoietin-resistant anaemia in dialysis patients (Review)

Badve Sunil V., Beller, Elaine M., Cass, Alan, Francis, Daniel P., Hawley, Carmel, Macdougall, Iain C., Perkovic, Vlado and Johnson, David W. (2013). Interventions for erythropoietin-resistant anaemia in dialysis patients (Review). Cochrane Database of Systematic Reviews, 2013 (8) CD006861. doi: 10.1002/14651858.CD006861.pub3

Interventions for erythropoietin-resistant anaemia in dialysis patients (Review)

2013

Journal Article

The HONEYPOT randomized controlled trial: statistical analysis plan

Pascoe, Elaine Mary, Lo, Serigne, Scaria, Anish, Badve, Sunil V., Beller, Elaine Mary, Cass, Alan, Hawley, Carmel Mary and Johnson, David W. (2013). The HONEYPOT randomized controlled trial: statistical analysis plan. Peritoneal Dialysis International, 33 (4), 426-435. doi: 10.3747/pdi.2012.00310

The HONEYPOT randomized controlled trial: statistical analysis plan

2013

Journal Article

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013)

Petchey, William G., Hickman, Ingrid J., Prins, Johannes B., Hawley, Carmel M., Johnson, David W., Isabel, Nicole M. and Duncan, Emma L. (2013). Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013). Nephrology, 18 (6), 481-481. doi: 10.1111/nep.12095

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013)

2013

Journal Article

The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand

Tang, Wen, Bose, Bhadran, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., Peh, Chen Au and Johnson, David W. (2013). The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand. Clinical Journal of the American Society of Nephrology, 8 (5), 773-780. doi: 10.2215/CJN.08770812

The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand

2013

Journal Article

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease

Tang, Wen, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil C., Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., de Zoysa, Janak R. and Johnson, David W. (2013). Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. Kidney International, 83 (3), 503-510. doi: 10.1038/ki.2012.375

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease

2013

Journal Article

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases

Tang, Wen, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., de Zoysa, Janak R. and Johnson, David W. (2013). End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. Nephrology Dialysis Transplantation, 28 (2), 455-461. doi: 10.1093/ndt/gfs492

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases

2013

Journal Article

Cardiac surgical outcomes in abdominal solid organ (renal and hepatic) transplant recipients: a case-matched study

Sharma, Rajiv, Hawley, Carmel, Griffin, Raylene, Mundy, Julie, Peters, Paul and Shah, Pallav (2013). Cardiac surgical outcomes in abdominal solid organ (renal and hepatic) transplant recipients: a case-matched study. Interactive Cardiovascular and Thoracic Surgery, 16 (2), 103-111. doi: 10.1093/icvts/ivs442

Cardiac surgical outcomes in abdominal solid organ (renal and hepatic) transplant recipients: a case-matched study

2013

Journal Article

Outcomes of extended-hours hemodialysis performed predominantly at home

Jun, M., Jardine, Meg J., Gray, Nicholas, Masterson, Rosemary, Kerr, Peter G., Agar, John W. M., Hawley, Carmel M., van Eps, Carolyn, Cass, Alan, Gallagher, Martin and Perkovic, Vlado (2013). Outcomes of extended-hours hemodialysis performed predominantly at home. American Journal of Kidney Diseases, 61 (2), 247-253. doi: 10.1053/j.ajkd.2012.08.032

Outcomes of extended-hours hemodialysis performed predominantly at home

2013

Conference Publication

Long term prediction of cardiovascular death in a population with end stage kidney disease

Burrage, M., Haluska, B., Krishnasamy, R., Hawley, C., Isbel, N., Marwick, T. and Stanton, T. (2013). Long term prediction of cardiovascular death in a population with end stage kidney disease. Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting, Gold Coast, Australia, 8-11 August 2013. Chatswood, NSW, Australia: Elsevier.

Long term prediction of cardiovascular death in a population with end stage kidney disease

2013

Conference Publication

The Impact of Haemodiafiltration, Haemofiltration and Haemodialysis On Clinical Outcomes: a Systematic Review and Meta-Analysis

Wang, A., Al-Kahwa, A., Perkovic, V., Gallagher, M., Hawley, C. and Jardine, M. (2013). The Impact of Haemodiafiltration, Haemofiltration and Haemodialysis On Clinical Outcomes: a Systematic Review and Meta-Analysis. WILEY-BLACKWELL.

The Impact of Haemodiafiltration, Haemofiltration and Haemodialysis On Clinical Outcomes: a Systematic Review and Meta-Analysis

2013

Conference Publication

Global longitudinal strain is associated with obesity, inflammation, uremic toxins and arterial stiffness in patients with chronic kidney disease stages 3 and 4

Krishnasamy, R., Hawley, C., Campbell, K., Rossi, M., Coombes, J., Leano, R., Stanton, T. and Isbel, N. (2013). Global longitudinal strain is associated with obesity, inflammation, uremic toxins and arterial stiffness in patients with chronic kidney disease stages 3 and 4. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD, Australia, 9-11 September 2013. Richmond, VIC, Australia: Wiley-Blackwell.

Global longitudinal strain is associated with obesity, inflammation, uremic toxins and arterial stiffness in patients with chronic kidney disease stages 3 and 4

2013

Journal Article

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial

Petchey, William G., Hickman, Ingrid J., Prins, Johannes B., Hawley, Carmel M., Johnson, David W. and Isbel, Nicole M. (2013). Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial. Nephrology, 18 (1), 26-35. doi: 10.1111/j.1440-1797.2012.01662.x

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial